GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹273 Cr | ₹293 Cr | ₹222 Cr | ₹192 Cr | ₹205 Cr |
What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹273 Cr |
| Mar2025 | ₹293 Cr |
| Mar2024 | ₹222 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹205 Cr |
How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹273 Cr | -6.64 | |
| Mar2025 | ₹293 Cr | 31.75 | |
| Mar2024 | ₹222 Cr | 15.43 | |
| Mar2023 | ₹192 Cr | -6.27 | |
| Mar2022 | ₹205 Cr | - | |
Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹49,119.2 Cr | 7.4% | 16.3% | 8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 7.4% |
16.3% |
8.4% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses